France / CIS 66705623

HYDROSOL POLYVITAMINE PHARMA DEVELOPPEMENT, solution buvable en gouttes

solution buvable en gouttes · orale

Directory source checks passedOriginal source language: French

Source data retrieved: 2026-09-17. Clinical review is not yet available.

Formsolution buvable en gouttes
Routeorale
Ingredient entries9
CountryFrance

Product identity

At a glance

Authorisation holder
PHARMA DEVELOPPEMENT
Authorisation status
Autorisation active
Market status
Commercialisée
Country
France
Source reference
CIS 66705623

Reported market status does not confirm current pharmacy stock.

From the official composition record

Ingredients & strength

Source entries are shown individually. An active substance (SA) and its reference moiety (FT) may describe the same ingredient; do not add their strengths together.

Source composition entries for HYDROSOL POLYVITAMINE PHARMA DEVELOPPEMENT, solution buvable en gouttes
IngredientStrength / referenceSource role
ACIDE ASCORBIQUEsolution2 500 mg100 ml de solution buvableSAGroup 8
ERGOCALCIFÉROLsolution50 000 UI100 ml de solution buvableSAGroup 2
CHLORHYDRATE DE THIAMINEsolution100 mg100 ml de solution buvableSAGroup 4
DEXPANTHÉNOLsolution200 mg100 ml de solution buvableSAGroup 9
NICOTINAMIDEsolution500 mg100 ml de solution buvableSAGroup 7
ACÉTATE D'ALPHA-TOCOPHÉROLsolution100 mg100 ml de solution buvableSAGroup 3
CHLORHYDRATE DE PYRIDOXINEsolution100 mg100 ml de solution buvableSAGroup 5
PHOSPHATE SODIQUE DE RIBOFLAVINEsolution75 mg100 ml de solution buvableSAGroup 6
CONCENTRAT DE VITAMINE A SYNTHÉTIQUE, FORME HUILEUSEsolution250 000 UI100 ml de solution buvableSAGroup 1

Pack references

Presentations (1)

1 flacon(s) en verre brun compte-gouttes (incorporé) polyéthylène basse densité (PEBD) de 20 ml

CIP13 3400937714884

Présentation active · Déclaration de commercialisation

From the French medicines authority

Official documents

The official product entry provides access to the patient leaflet and professional product information when available. Documents are in French and availability varies by medicine.

Open the official product entryBDPM · CIS 66705623 · Opens in a new tab

Check the medicine name, strength and form against your pack. The authority’s current documents may be newer than the catalogue snapshot shown here.

Where this information comes from

Sources & dates

Base de données publique des médicaments (BDPM), France. Retrieval dates record when we obtained the source files; they are not clinical review dates or a guarantee of current stock.

Source files and their retrieval dates
Source fileRetrievedSource file modified
fr_products.txtNot supplied
fr_composition.txtNot supplied
fr_packs.txtNot supplied

Directory source checks cover the factual catalogue record.Molindra clinical guidance has not yet been reviewed or published for this medicine.

Our sources and review process →